Updates are available Erratum dated 2017-09-18

Click to view Erratum: https://doi.org/10.1186/s13045-017-0518-8

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Crossref DOI link: https://doi.org/10.1186/s13045-016-0243-8

Published Online: 2016-03-10

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark